Pacira BioSciences Yönetim
Yönetim kriter kontrolleri 2/4
Pacira BioSciences CEO'su Frank Lee, Jan2024 tarihinde atandı, in görev süresi bir yıldan az. şirketin hisselerinin 0.018% doğrudan sahiptir ve bu hisselerin değeri $ 142.84K dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.5 yıl ve 5.2 yıldır.
Anahtar bilgiler
Frank Lee
İcra Kurulu Başkanı
n/a
Toplam tazminat
CEO maaş yüzdesi | n/a |
CEO görev süresi | less than a year |
CEO sahipliği | 0.02% |
Yönetim ortalama görev süresi | 2.5yrs |
Yönetim Kurulu ortalama görev süresi | 5.2yrs |
Son yönetim güncellemeleri
Recent updates
Pacira BioSciences, Inc. (NASDAQ:PCRX) Not Doing Enough For Some Investors As Its Shares Slump 34%
Sep 06Little Excitement Around Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Revenues As Shares Take 29% Pounding
Jul 23These 4 Measures Indicate That Pacira BioSciences (NASDAQ:PCRX) Is Using Debt Safely
Jun 07Pacira BioSciences, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
May 10Getting In Cheap On Pacira BioSciences, Inc. (NASDAQ:PCRX) Might Be Difficult
May 03Does Pacira BioSciences (NASDAQ:PCRX) Have A Healthy Balance Sheet?
Feb 05Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Low P/S No Reason For Excitement
Jan 05We Think Pacira BioSciences (NASDAQ:PCRX) Can Stay On Top Of Its Debt
Nov 03Is Pacira BioSciences (NASDAQ:PCRX) Using Too Much Debt?
Jul 28Pacira BioSciences, Inc.'s (NASDAQ:PCRX) Intrinsic Value Is Potentially 26% Below Its Share Price
Jul 07Is Pacira BioSciences (NASDAQ:PCRX) A Risky Investment?
Apr 18We Think Pacira BioSciences (NASDAQ:PCRX) Can Stay On Top Of Its Debt
Dec 28Assessing Pacira BioSciences' Growth Prospects
Oct 20Pacira BioSciences guides Q3 revenue below consensus
Oct 13Pacira, Sevāredent team up to expand access to pain drug Exparel for dental procedures
Sep 27EMA panel backs expanding indication for Pacira's postsurgical pain treatment in kids
Sep 20Pacira BioSciences records 17.7% sequential growth in August revenue
Sep 13Pacira BioSciences provides update on July product sales
Aug 10Pacira BioSciences Q2 2022 Earnings Preview
Aug 02Pacira BioSciences sees Q2 revenue below consensus
Jul 14CEO
Frank Lee (56 yo)
less than a year
Görev süresi
Mr. Frank D. Lee served as an Independent Director at Bolt Biotherapeutics, Inc. since November 2021 until September 2024. He is Independent Director of Bausch Health Companies Inc. from May 14, 2024. He i...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Chief Operating Officer | 2.5yrs | US$1.53m | 0.027% $ 211.7k | |
Chief Administrative Officer & Secretary | 10.1yrs | US$1.60m | 0% $ 0 | |
Advisor | less than a year | US$6.88m | 0.51% $ 4.1m | |
Executive Officer | less than a year | US$1.43m | 0.059% $ 473.9k | |
Chief Medical Officer | 3.3yrs | US$1.59m | 0.028% $ 224.3k | |
CEO & Director | less than a year | Veri yok | 0.018% $ 142.8k | |
Chief Financial Officer | less than a year | Veri yok | Veri yok | |
Principal Accounting Officer & Senior VP of Finance | 12.7yrs | US$288.82k | 0.0046% $ 37.0k | |
Head of Investor Relations | no data | Veri yok | Veri yok | |
Chief Legal & Compliance Officer | 2.9yrs | US$2.05m | 0.028% $ 222.5k | |
Vice President of Human Resources | 9.3yrs | Veri yok | Veri yok | |
Chief Manufacturing Officer | 1.6yrs | Veri yok | Veri yok |
2.5yrs
Ortalama Görev Süresi
54yo
Ortalama Yaş
Deneyimli Yönetim: PCRX 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.5 yıldır).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
CEO & Director | less than a year | Veri yok | 0.018% $ 142.8k | |
Independent Director | 13.4yrs | US$364.01k | 0.027% $ 212.9k | |
Chairman of the Board | 13.4yrs | US$390.51k | 0.016% $ 129.5k | |
Independent Director | 17.9yrs | Veri yok | Veri yok | |
Independent Director | 11.4yrs | US$373.01k | 0.043% $ 340.0k | |
Independent Director | 5.2yrs | US$325.01k | 0.011% $ 90.9k | |
Independent Director | 1.1yrs | US$427.86k | 0% $ 0 | |
Independent Director | 1.1yrs | US$426.45k | 0.011% $ 84.9k | |
Independent Director | 1.1yrs | US$427.16k | 0% $ 0 | |
Independent Director | 7.4yrs | US$349.01k | 0.020% $ 159.7k | |
Independent Director | 1.1yrs | US$427.16k | 0.0043% $ 34.6k |
5.2yrs
Ortalama Görev Süresi
62.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: PCRX 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.2 yıldır).